Publications by authors named "Tiffany Ricks"

Claim this Profile
F
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.
Melanie Royce, Mirat Shah, Lijun Zhang, Joyce Cheng, Mary Kate Bonner, Tiffany K Ricks

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.
Jennifer J Gao, Tatiana M Prowell, Haley Gittleman, Joyce Cheng, Mallorie Fiero, Tiffany K Ricks

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ.
Brian L Heiss, Elaine Chang, Hee-Koung Joeng, Mallorie H Fiero, Lingshan Wang, Tiffany K Ricks

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, -Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Locally Advanced or Metastatic Breast Cancer.
Suparna Wedam, Preeti Narayan, Haley Gittleman, Joyce Cheng, Vishal Bhatnagar, Tiffany Ricks

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
William F Maguire, Dow-Chung Chi, Sundeep Agrawal, Hee-Koung Joeng, Sarah Kim-McOlash, Tiffany K Ricks

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
Mirat Shah, Ting-Yu Chen, Gwynn Ison, Mallorie H Fiero, Hui Zhang, Tiffany K Ricks

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With // Alterations.
Asma Dilawari, James Buturla, Christy Osgood, Xin Gao, Wei Chen, Tiffany K Ricks

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.
Sundeep Agrawal, Clara Lee, William F Pierce, Elizabeth Everhart, Adriene King-Ducre, Tiffany K Ricks

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability and Racial Justice Go Hand in Hand: A Commentary on Black Men and Firearm Violence.
Nazsa S Baker, William Wical, Tiffany N Ricks

Am J Mens Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Tiffany K Ricks

J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditions that influence coping mechanisms in Latina mothers affected by incarceration: A secondary analysis using the vulnerability framework.
Allison D Crawford, Tiffany N Ricks, Kelly McGlothen Bell, Jacqueline M McGrath, Christine Abbyad

Res Nurs Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, -Mutated Advanced or Metastatic Breast Cancer.
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Tiffany K Ricks

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Equity in Maternal Health Care.
Elizabeth Polinard, Tiffany Nicole Ricks, Chris Abbyad

Am J Nurs· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What nurses must understand about the ethics of assisted dying.
Esme D West, Tiffany N Ricks

Nurs Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With -Mutated Metastatic Castration-Resistant Prostate Cancer.
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik Bloomquist, Tiffany Ricks

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protect and Provide: Perceptions of Manhood and Masculinities Among Disabled Violently Injured Black Men in a Hospital-Based Violence Intervention Program.
Nazsa S Baker, Cortney VanHook, Tiffany Ricks, Christopher St Vil, Teri Lassiter

Am J Mens Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
Jennifer J Gao, Christy L Osgood, Zhou Feng, Erik W Bloomquist, Shenghui Tang, Tiffany K Ricks

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer.
Asma Dilawari, Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H Fiero, Tiffany K Ricks

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is Known About Reproductive Autonomy Among Justice-Involved Black Women?: A Scoping Review.
Allison D Crawford, Tiffany N Ricks, Elizabeth Polinard, Christine W Abbyad

J Transcult Nurs· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H Fiero, Sriram Subramaniam, Tiffany K Ricks

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Jaleh Fallah, Michael H Brave, Chana Weinstock, Gautam U Mehta, Diana Bradford, Tiffany K Ricks

Clin Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undoing Racism and Mitigating Bias Among Healthcare Professionals: Lessons Learned During a Systematic Review.
Tiffany N Ricks, Christine Abbyad, Elizabeth Polinard

J Racial Ethn Health Disparities· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic perspectives from the frontline-The nursing stories.
Elizabeth L Polinard, Tiffany N Ricks, Ellen Stoetzner Duke, Kimberly A Lewis

J Adv Nurs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.
Melanie Royce, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, C J George Chang, Tiffany K Ricks

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.
Elaine Chang, Chana Weinstock, Lijun Zhang, Mallorie H Fiero, Miao Zhao, Tiffany K Ricks

Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis